Simson Jake

Simson Jake is listed in filings as Director at Tyra Biosciences, Inc.. This profile follows SEC Form 4 activity through Jun 1, 2026, including 9 public disclosures. Recent filings connect the profile to Tyra Biosciences, Inc. (TYRA), Septerna, Inc. (SEPN), Janux Therapeutics, Inc. (JANX), and Bicara Therapeutics Inc. Common Stock (BCAX). The current snapshot covers public activity from Jun 28, 2024 to Jun 1, 2026. Reported amounts are shown as $205.3K to $170.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.